Compare RYAAY & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAAY | STE |
|---|---|---|
| Founded | 1985 | 1985 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1B | 25.9B |
| IPO Year | 1997 | 1992 |
| Metric | RYAAY | STE |
|---|---|---|
| Price | $72.40 | $255.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $76.00 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 1.1M | 666.1K |
| Earning Date | 01-26-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.14% | 0.99% |
| EPS Growth | ★ 62.72 | 59.39 |
| EPS | 2.57 | ★ 6.97 |
| Revenue | ★ $17,686,260,708.00 | $5,702,415,000.00 |
| Revenue This Year | $11.08 | $9.61 |
| Revenue Next Year | $5.20 | $6.23 |
| P/E Ratio | ★ $13.13 | $36.43 |
| Revenue Growth | ★ 11.16 | 7.08 |
| 52 Week Low | $38.52 | $200.98 |
| 52 Week High | $72.61 | $268.60 |
| Indicator | RYAAY | STE |
|---|---|---|
| Relative Strength Index (RSI) | 72.85 | 49.97 |
| Support Level | $70.23 | $250.46 |
| Resistance Level | $71.82 | $255.31 |
| Average True Range (ATR) | 1.21 | 4.84 |
| MACD | 0.41 | -1.24 |
| Stochastic Oscillator | 98.07 | 41.00 |
Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.